ATRC
NASDAQ
$34.77
Atricure Inc (ATRC)
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.
Sector:
Healthcare
Industry:
Medical Instruments & Supplies
Buy
Target: $47 (+35.17%)
Market Cap
$1.75B
Revenue 5Y CAGR
+21.03%
Free Cash Flow Yield
3.07%
Beta (5Y)
0.91
Price Chart
Valuation
Market Cap$1.75B
Forward P/E434.78
PEG10.00
P/S3.27
P/B3.56
Profitability
Total Revenue (TTM)$552M
Gross Profit (TTM)$417M
EBITDA$9.04M
Profit Margin0.1%
Operating Margin0.4%
EPS-$0.09
Financial Health
Debt-to-Equity12.4%
Free Cash Flow Yield3.07%
Growth & Risk
EPS 5Y CAGR-39.18%
Revenue 5Y CAGR+21.03%
Beta (5Y)0.91
Sharpe Ratio0.49